Dr. Song co-founded Genome Opinion and leads clinical development activities and genetic testing NGS lab. Previously, Dr. Song worked as senior staff scientist at Genome Analytics group of Samsung SDS.



  • PhD. Bio-Medical Science, Korea University



  • The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes. Endocrinology and Metabolism, 2022
  • Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea. Atherosclerosis, 2022
  • Clonal hematopoiesis is associated with risk of severe Covid-19. Nature Communications, 2021
  • Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. Journal of Allergy and Clinical Immunology, 2016

Han Song, PHD

Co-Founder, Chief Development Officer